Clinerion’s network expands into India with AlphaMD partnership

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Yuji Sakai)
(Image: Getty/Yuji Sakai)

Related tags: India, Clinerion, Patient recruitment, Clinical trials, Clinical trial

Clinerion expands into India’s hospital ecosystem to accelerate trial recruitment and site selection as it partners Alpha MD.

Through the partnership with the global clinical research consultancy company, Alpha MD, Indian patients may be matched with international research studies as Indian health care organizations are brought on to Clinerion’s patient network explorer platform.

A spokesperson for Clinerion told us, “India has excellent medical facilities and experts, but its large patient population is not yet fully accessible for clinical studies. Doing trials in India also allows pharma the possibility to develop treatments for the diverse local populations of India.”

Clinerion’s patient network explorer platform brings international clinical studies to the country and enables expanded patient care and trial access using the company’s patented anonymized patient identification technology​ and hospital network.

The Clinerion spokesperson explained that the patient network explorer will also be used to make decisions for the siting of clinical studies in India. The network enables the trial sponsor to have a view into the eligible patient population in each partner site and highlights where clusters of eligible patients are, speeding up trial recruitment.

The company’s patient research network has expanded throughout recent years through partnerships and has entered into countries such as Georgia​, Poland​, Greece​, Estonia, and Turkey​.

Related news

Show more

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars